In the current study, we investigated whether androgen could activate ELK1, as a downstream target of AR, in bladder cancer cells as well as whether ELK1 could affect their proliferation and migration in the presence and absence of androgen. The gene discussed is ELK1; the disease is urinary bladder cancer.